Kane Biotech Inc. (KNE.V) TSXV

0.05

+0(+0.00%)

Updated at January 19 12:04PM

Currency In CAD

Valuation

Market Cap14.73M
Enterprise Value16.66M
P/E Ratio-3.87
PEG Ratio-0.56
Price/Sales Ratio13.1
Price/Book Ratio-9.49
Enterprise/Revenue15.46
Enterprise/EBITDA-3.21

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-3.39
Operating Margin-5.36

Management Effectiveness

Return On Assets-0.71
Return On Equity2.05

Income Statement

Revenue2.08M
Revenue/Share0
Gross Profit872,096
EBITDA-3.71M
Net Income-3.02M
Diluted EPS-0.02

Balance Sheet

Total Cash939,062
Total Cash/Share0.01
Total Debt2.3M
Total Debt/Equity-2.9
Current Ratio0.9
Book Value Per Share-0

Price History

52-Week Change-57.14
52-Week High0.12
52-Week Low0.03
Moving Average 50 Days0.04
Moving Average 200 Days0.05

Statistics

Average Volume236,181
Shares Outstanding167.35M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:5
Last Split DateMarch 13, 2017